Valio continues research into probiotic fruit juices

By Stephen Daniells

- Last updated on GMT

Related tags Pasteurization Juice functional beverage beverage

Finnish company Valio is continuing R&D into fruit juice-based
probiotics, with a study in the journal LWT reporting
excellent stability, survivability and tolerability of two strains.

The company has been marketing its Gefilus brand of probiotic juices in Finland since 1997 and says they are now the biggest selling product in Finland's refrigerated juice section.

Adding probiotics to juices is more complex than formulating in dairy products because the bacteria need protection from the acidic conditions in fruit juice.

The new research, led by Tarja Suomalainen from Valio (now with the Raisio Group), looked at using L. rhamnosus​ VTT E-97800 (E800) and L. rhamnosus​ Lc705 in a whey-based fruit juice. The latter was from Valio's commercial Bioprofit product, with the strain P. freudenreichii​ ssp. shermanii​ JS also present.

The strains were added to Valio's commercially available Hedelmätarha product - a whey-based orange drink enriched with calcium. The new formulations were tested in a single blind parallel study with 22 healthy adult volunteers. People with GI tract diseases or recent antibiotic consumption were excluded from the trial.

The trial was designed to give two weeks of baseline control, followed by two weeks of supplementation with either the E800 drink (11 people) or the Lc705 drink (11 people), followed by a final two weeks of follow-up.

"Excellent survival of L. rhamnosus E800 and Lc705 strains during storage in the low pH juice matrix and in the GI-tract was demonstrated in the present study,"​ wrote Suomalainen.

No significant change of immune function of the subjects was observed, although the Lc705 juice drink did decrease the number of IgA cells.

"Although the decrease was statistically significant, it is not certain whether it is biologically relevant,"​ said Suomalainen.

Self-reporting of faecal consistency showed no significant differences, but frequency of defecation increased for the Lc705 group. The E800 group did not report any changes during and after consumption.

"Thus the added bacteria were not disturbing the normal healthy balance in the intestine,"​ concluded Suomalainen.

No one from Valio was available for comment and it is not known if the company will develop these specific whey-based probiotics for commercialisation.

The probiotics market is already one of the fastest growing sectors in fresh dairy markets with a retail growth of about 12 per cent, according to Euromonitor.

The research was published in the journal LWT - Food Science and Technology​ (Vol. 39, pp. 788-795).

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

Related suppliers

Follow us


View more